Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased Serum Levels of Tumor Necrosis Factor-like Ligand 1A in Atopic Dermatitis. | Int J Mol Sci | 2023 | 36768135 | PubTator, text mining | PubMed |
| Short-Term Treatment with Rho-Associated Kinase Inhibitor Preserves Keratinocyte Stem Cell Characteristics In Vitro. | Cells | 2023 | 36766688 | PubTator, text mining | PubMed |
| Enabling Single-Cell Drug Response Annotations from Bulk RNA-Seq Using SCAD. | Adv Sci (Weinh) | 2023 | 36762572 | PubTator, text mining | PubMed |
| A mechanistic evaluation of human beta defensin 2 mediated protection of human skin barrier in vitro. | Sci Rep | 2023 | 36755116 | PubTator, text mining | PubMed |
| Protective effect of Saussurea involucrata polysaccharide against skin dryness induced by ultraviolet radiation. | Front Pharmacol | 2023 | 36733502 | PubTator, text mining | PubMed |
| Cannabidiol mediates epidermal terminal differentiation and redox homeostasis through aryl hydrocarbon receptor (AhR)-dependent signaling. | J Dermatol Sci | 2023 | 36725458 | PubTator, text mining | PubMed |
| Induction of psoriasis- and atopic dermatitis-like phenotypes in 3D skin equivalents with a fibroblast-derived matrix. | Sci Rep | 2023 | 36720910 | PubTator, text mining | PubMed |
| Development of Hetero-Cell Type Spheroids Via Core-Shell Strategy for Enhanced Wound Healing Effect of Human Adipose-Derived Stem Cells. | Tissue Eng Regen Med | 2023 | 36708468 | PubTator, text mining | PubMed |
| Engineering edgeless human skin with enhanced biomechanical properties. | Sci Adv | 2023 | 36706190 | PubTator, text mining | PubMed |
| Alleviation of imiquimod-induced psoriasis-like symptoms in Rorα-deficient mouse skin. | BMB Rep | 2023 | 36698281 | PubTator, text mining | PubMed |
| TRPV3-ANO1 interaction positively regulates wound healing in keratinocytes. | Commun Biol | 2023 | 36690845 | PubTator, text mining | PubMed |
| Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma. | Nat Commun | 2023 | 36690674 | PubTator, text mining | PubMed |
| 3D bioprinting of an implantable xeno-free vascularized human skin graft. | Bioeng Transl Med | 2023 | 36684084 | PubTator, text mining | PubMed |
| DNA damage triggers squamous metaplasia in human lung and mammary cells via mitotic checkpoints. | Cell Death Discov | 2023 | 36681661 | PubTator, text mining | PubMed |
| Identification and In Silico Analysis of a Homozygous Nonsense Variant in TGM1 Gene Segregating with Congenital Ichthyosis in a Consanguineous Family. | Medicina (Kaunas) | 2023 | 36676727 | PubTator, text mining | PubMed |
| Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases. | Int J Mol Sci | 2023 | 36674974 | PubTator, text mining | PubMed |
| Full Skin Equivalent Models for Simulation of Burn Wound Healing, Exploring Skin Regeneration and Cytokine Response. | J Funct Biomater | 2023 | 36662076 | PubTator, text mining | PubMed |
A Randomized, Controlled Clinical Trial of a Dermocosmetic Containing Vichy Volcanic Mineralizing Water and Probiotic Fractions in Subjects with Rosacea Associated with Erythema and Sensitive Skin and Wearing Protective Masks. | Clin Cosmet Investig Dermatol | 2023 | 36660190 | PubTator, text mining | PubMed |
| Involucrin Modulates Vitamin D Receptor Activity in the Epidermis. | J Invest Dermatol | 2023 | 36642403 | PubTator, text mining | PubMed |
| Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening. | Cell Death Dis | 2023 | 36631452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=20